Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (236)
- COVID-19 (55)
- Compliance and enforcement (48)
- Vaping hub (33)
- Import and export (21)
- Medicinal cannabis hub (19)
- Safety monitoring and information (13)
- Scheduling (national classification system) (13)
- Manufacturing (11)
- Weight loss products (8)
- Legislation (7)
- Labelling and packaging (4)
- Shortages and supply disruptions (4)
- Cosmetics (3)
- Prescription opioids hub (2)
- Unique Device Identification (UDI) hub (2)
- Committees and advisory bodies (1)
- Fees and payments (1)
- Sunscreens (1)
Search
530 result(s) found, displaying 426 to 450
-
Media releasesInSkin Cosmedics Group Pty Ltd has paid penalties of $37,800 in regards to the alleged supply and advertising of the Dermapen 4
-
Media releasesMeasles vaccine testing shows the vaccine meets required standards
-
-
Media releasesPharmacies and others can advertise availability of OTC salbutamol products during the bushfire season
-
Media releasesMundipharma Pty Ltd has paid penalties of $302,400 in response to 24 infringement notices issued by the TGA
-
-
Media releasesWe will closely consider the judgment including any further improvements that could enhance the regulatory system in Australia.
-
Media releasesAcalabrutinib receives approval through the second international collaborative review initiative between the TGA, FDA and Health Canada
-
Media releasesThe TGA has joined the ICMRA and the WHO in a coordinated global approach to fighting antimicrobial resistance
-
Media releasesConsumer Healthcare Products Australia to handle all medicine advertising pre-approval applications
-
Media releasesThe Complementary Healthcare Council of Australia is no longer accepting advertising pre-approval applications
-
Media releasesThe Therapeutic Goods Administration is aware that a member of the public has purported to be a Commonwealth public official during a recent incident in Melbourne
-
Media releasesA warning to consumers about undergoing procedures using unapproved medical devices
-
Media releasesChanges are coming in November to the advertising pre-approval arrangements for some complementary medicines advertisements
-
Media releasesThe TGA has released the findings of its review into breast implants and breast tissue expanders
-
Media releasesInternational Collaborative Review Initiative gives provisional approval of lenvatinib in combination with pembrolizumab
-
Media releasesInfringement notice issued for the alleged advertising of Schedule 4 substances
-
Media releasesInfringement notice issued for the alleged advertising of a cancelled therapeutic good
-
Media releasesUpdate on amendments to the Therapeutic Goods Advertising Code (No.2) 2018 and medicines advertising pre-approval
-
Media releasesThe TGA has commenced work on a sector-wide compliance activity relating to the advertising of bioresonance devices
-
Media releasesAn individual has been fined for the alleged importation of unapproved cosmetic products after returning from an overseas trip to China
-
Media releasesInfringement notices issued for the alleged importation and advertising of unapproved performance and image enhancing products
-
Media releasesInformation on how supplements are regulated in Australia
-
Media releasesImprovements to Consumer Medicine Information
-
Media releasesImportant information about the dangers of using thermography for breast cancer detection